| | Morphology | Gender | Total all-age incidence, no. 103(95% UI) | Age-standardized incidence rate (95% UI), per 100,000 | | 1990 | 2019 | Change, % | 1990 | 2019 | Change, % |
| | All neoplasms | Male | 989.39 (771.24, 1204.75) | 2639.01 (2074.05, 3272.87) | 166.73 | 233.48 (185.78, 281.18) | 294.59 (233.01, 362.05) | 26.17 | | Female | 703.89 (547.24, 879.33) | 1816.78 (650.32, 2265.26) | 158.11 | 154.51 (121.09, 191.46) | 181.72 (140.07, 226.34) | 27.21 | | Both | 1693.28 (1379.69, 2013.50) | 4551.17 (3716.31, 5453.52) | 168.78 | 190.18 (156.49, 224.19) | 232.42 (190.76, 277.19) | 22.21 |
| | Tracheal, bronchus, and lung cancer | Male | 178.99 (145.48,213.93) | 576.19 (451.4,709.27) | 221.91 | 44.29 (36.72,52.43) | 61.74 (48.93,75.20) | 39.40 | | Female | 78.05 (65.13,91.71) | 256.74 (205.68,314.16) | 228.94 | 18.01 (15.12,21.04) | 24.76 (19.89,30.26) | 37.48 | | Both | 257.04 (221.29,293.65) | 832.92 (700.29,981.63) | 224.04 | 30.20 (26.20,34.26) | 41.71 (35.22,48.80) | 38.11 |
| | Stomach cancer | Male | 207.53 (173.24,245.61) | 451.33 (357.18,560.15) | 117.48 | 51.07 (42.99,59.92) | 47.35 (38,57.95) | -7.28 | | Female | 109.81 (92.09,127.87) | 161.49 (130.60,198.34) | 47.06 | 25.57 (21.49,29.61) | 15.80 (12.80,19.38) | -38.21 | | Both | 317.34 (277.90,359.32) | 612.82 (513.00,728.89) | 93.11 | 37.56 (33.08,42.27) | 30.64 (25.82,36.15) | -18.42 |
| | Colorectal cancer | Male | 56.86 (47.48,66.81) | 390.2 (310.20,484.11) | 586.25 | 14.16 (12.03,16.43) | 41.43 (33.41,50.87) | 192.58 | | Female | 49.05 (40.80,57.12) | 217.7 (175.11,268.36) | 343.83 | 11.30 (9.47,13.12) | 21.10 (17.00,26.04) | 86.73 | | Both | 105.91 (93.81,119.02) | 607.9 (521.80,708.42) | 473.98 | 12.52 (11.15,14.03) | 30.55 (26.37,35.50) | 144.01 |
| | Breast cancer | Male | 0.55 (0.45,0.66) | 7.11 (5.34,9.08) | 1192.73 | 0.13 (0.10,0.15) | 0.69 (0.53,0.88) | 430.77 | | Female | 81.07 (66.34,96.52) | 368.37 (290.09,463.34) | 354.39 | 17.07 (14.02,20.30) | 35.61 (28.07,44.81) | 108.61 | | Both | 81.62 (66.87,97.10) | 375.48 (296.63,469.98) | 360.03 | 8.54 (7.07,10.11) | 18.32 (14.5,22.93) | 114.52 |
| | Prostate cancer | Male | 26.44 (20.10,31.92) | 153.45 (118.4,204.94) | 480.37 | 8.88 (7.14,10.86) | 17.34 (13.62,22.72) | 95.27 |
| | Non-melanoma skin cancer | Male | 20.87 (17.61,24.97) | 157.05 (135.07,179.13) | 652.52 | 5.19 (4.45,6.05) | 16.35 (14.28,18.6) | 215.03 | | Female | 18.70 (15.61,22.43) | 130.89 (111.88,150.19) | 599.95 | 4.29 (3.62,5.04) | 12.72 (10.94,14.51) | 196.50 | | Both | 39.57 (33.25,47.49) | 287.94 (246.82,328.67) | 627.67 | 4.68 (3.96,5.48) | 14.32 (12.36,16.31) | 205.98 |
| | Esophageal cancer | Male | 115.47 (75.12,140.39) | 207.92 (156.07,258.29) | 80.06 | 28.7 (19.23,34.41) | 21.94 (16.40,27.03) | -23.55 | | Female | 58.21 (32.17,69.77) | 70.20 (46.04,88.57) | 20.60 | 13.94 (7.82,16.58) | 6.83 (4.45,8.61) | -51.00 | | Both | 173.69 (112.11,203.39) | 278.12 (213.51,331.60) | 60.12 | 20.97 (13.62,24.33) | 13.9 (10.7,16.52) | -33.71 |
| | Cervical cancer | Female | 40.68 (30.92,73.18) | 109.76 (58.19,141.54) | 169.81 | 8.41 (6.44,15) | 11.01 (5.87,14.22) | 30.92 |
| | Leukemia | Male | 72.91 (46.41,93.79) | 85.26 (64.06,105.89) | 16.94 | 12.70 (8.33,16.31) | 11.42 (8.52,14.03) | -10.08 | | Female | 69.81 (49.27,88.63) | 69.39 (52.7,86.51) | -0.60 | 12.90 (9.18,16.32) | 9.59 (7.34,11.75) | -25.66 | | Both | 142.72 (102.38,172.53) | 154.65 (127.21,181.08) | 8.36 | 12.71 (9.22,15.31) | 10.47 (8.70,12.34) | -17.62 |
| | Liver cancer | Male | 170.12 (137.51,206.72) | 159.79 (127.26,198.81) | -6.07 | 36.44 (29.58,44.21) | 16.36 (13.14,20.22) | -55.10 | | Female | 66.71 (54.24,82.01) | 50.68 (40.88,62.35) | -24.03 | 14.97 (12.25,18.32) | 4.94 (3.99,6.06) | -67.00 | | Both | 236.82 (199.32,280.12) | 210.46 (174.83,251.2) | -11.13 | 25.71 (21.73,30.35) | 10.46 (8.74,12.42) | -59.32 |
| | Uterine cancer | Female | 24.28 (18.18,29.96) | 66.74 (51.38,92.05) | 174.88 | 5.13 (3.89,6.29) | 6.39 (4.89,8.74) | 24.56 |
| | Pancreatic cancer | Male | 15.83 (12.77,19.08) | 69.64 (55.22,86.08) | 339.92 | 3.89 (3.19,4.64) | 7.43 (5.96,9.09) | 91.00 | | Female | 10.94 (9.21,12.67) | 45.33 (36.45,55.80) | 314.35 | 2.55 (2.16,2.96) | 4.36 (3.51,5.37) | 70.98 | | Both | 26.77 (23.13,30.26) | 114.96 (98.05,133.71) | 329.44 | 3.17 (2.77,3.57) | 5.78 (4.94,6.69) | 82.33 |
| | Brain and central nervous system cancer | Male | 25.09 (16.49,37.77) | 47.07 (30.53,61.74) | 87.60 | 4.84 (3.21,7.23) | 5.64 (3.61,7.33) | 16.53 | | Female | 20.76 (13.75,28.16) | 47.62 (34.83,62.14) | 129.38 | 4.09 (2.75,5.55) | 5.83 (4.30,7.77) | 42.54 | | Both | 45.85 (35.18,61.35) | 94.69 (73.40,114.09) | 106.52 | 4.45 (3.47,5.94) | 5.69 (4.36,6.78) | 27.87 |
| | Nasopharynx cancer | Male | 20.88 (17.07,24.83) | 82.91 (64.82,103.69) | 297.08 | 4.32 (3.55,5.10) | 8.55 (6.75,10.65) | 97.92 | | Female | 11.18 (8.92,13.37) | 27.53 (21.33,35.04) | 146.24 | 2.33 (1.88,2.77) | 2.83 (2.19,3.59) | 21.46 | | Both | 32.06 (27.39,36.56) | 110.43 (90.34,132.40) | 244.45 | 3.31 (2.84,3.76) | 5.65 (4.67,6.75) | 70.69 |
| | Bladder cancer | Male | 18.36 (15.42,21.45) | 82.68 (66.13,100.84) | 350.33 | 5.46 (4.67,6.26) | 9.38 (7.63,11.30) | 71.79 | | Female | 7.19 (5.92,8.61) | 17.34 (13.6,21.66) | 141.17 | 1.75 (1.45,2.09) | 1.72 (1.35,2.14) | -1.71 | | Both | 25.55 (22.27,29.01) | 100.02 (83.24,118.65) | 291.47 | 3.30 (2.89,3.72) | 5.16 (4.33,6.10) | 56.36 |
| | Non-Hodgkin lymphoma | Male | 11.72 (9.47,14.57) | 60.6 (47.98,76.02) | 417.06 | 2.40 (1.97,2.93) | 6.77 (5.44,8.35) | 182.08 | | Female | 8.36 (6.78,10.31) | 31.35 (25.14,38.73) | 275.00 | 1.71 (1.41,2.06) | 3.36 (2.72,4.12) | 96.49 | | Both | 20.08 (17.05,24.08) | 91.95 (76.98,108.97) | 357.92 | 2.04 (1.76,2.40) | 4.99 (4.24,5.87) | 144.61 |
| | Ovarian cancer | Female | 12.68 (9.91,17.51) | 45.48 (33.11,57.38) | 258.68 | 2.56 (2.00,3.58) | 4.54 (3.33,5.71) | 77.34 |
| | Kidney cancer | Male | 6.16 (5.06,7.48) | 42.55 (33.14,53.17) | 590.75 | 1.32 (1.09,1.60) | 4.63 (3.67,5.73) | 250.76 | | Female | 4.92 (4.24,5.68) | 17.27 (13.84,21.30) | 251.02 | 1.02 (0.88,1.17) | 1.92 (1.58,2.32) | 88.24 | | Both | 11.07 (9.79,12.59) | 59.83 (49.51,71.24) | 440.47 | 1.16 (1.02,1.31) | 3.21 (2.7,3.79) | 176.72 |
| | Testicular cancer | Male | 3.23 (2.56,4.40) | 17.17 (13.72,21.57) | 431.58 | 0.56 (0.45,0.75) | 2.39 (1.90,3.00) | 326.79 |
| | Lip and oral cavity cancer | Male | 7.06 (5.74,8.42) | 33.48 (26.15,42.01) | 374.22 | 1.68 (1.38,1.99) | 3.48 (2.75,4.31) | 107.14 | | Female | 5.33 (4.43,6.30) | 11.74 (9.47,14.48) | 120.26 | 1.17 (0.98,1.37) | 1.16 (0.94,1.43) | -0.85 | | Both | 12.39 (10.87,14.06) | 45.22 (37.69,54.18) | 264.97 | 1.40 (1.23,1.57) | 2.25 (1.89,2.68) | 60.71 |
| | Larynx cancer | Male | 11.03 (8.97,13.07) | 38.90 (30.45,48.73) | 252.67 | 2.68 (2.21,3.14) | 3.89 (3.07,4.84) | 45.15 | | Female | 3.05 (2.56,3.57) | 6.45 (5.13,7.88) | 111.48 | 0.70 (0.59,0.82) | 0.62 (0.49,0.75) | -11.43 | | Both | 14.09 (11.94,16.17) | 45.35 (36.75,55.36) | 221.86 | 1.63 (1.40,1.87) | 2.18 (1.78,2.65) | 33.74 |
| | Thyroid cancer | Male | 2.51 (2.04,3.10) | 16.11 (12.08,20.19) | 541.83 | 0.55 (0.45,0.67) | 1.74 (1.32,2.16) | 216.36 | | Female | 7.53 (5.91,9.31) | 22.97 (17.46,30.16) | 205.05 | 1.50 (1.19,1.86) | 2.41 (1.83,3.17) | 60.67 | | Both | 10.03 (8.4,11.91) | 39.08 (32.28,47.66) | 289.63 | 1.01 (0.86,1.21) | 2.05 (1.70,2.50) | 102.97 |
| | Gallbladder and biliary tract cancer | Male | 5.66 (4.40,9.48) | 19.76 (13.24,24.91) | 249.12 | 1.56 (1.25,2.51) | 2.25 (1.52,2.79) | 44.23 | | Female | 6.77 (5.29,11.59) | 18.87 (11.32,24.68) | 178.73 | 1.64 (1.27,2.82) | 1.84 (1.10,2.41) | 12.20 | | Both | 12.44 (10.31,20.01) | 38.63 (27.35,46.51) | 210.53 | 1.58 (1.32,2.51) | 2.01 (1.41,2.41) | 27.22 |
| | Multiple myeloma | Male | 3.04 (2.31,4.48) | 11.20 (7.47,14.92) | 268.42 | 0.72 (0.56,1.07) | 1.16 (0.77,1.54) | 61.11 | | Female | 3.03 (2.31,4.59) | 7.59 (5.20,9.87) | 150.50 | 0.69 (0.53,1.03) | 0.72 (0.49,0.94) | 4.35 | | Both | 6.07 (4.97,8.56) | 18.79 (13.68,23.33) | 209.56 | 0.70 (0.58,0.98) | 0.93 (0.67,1.15) | 32.86 |
| | Malignant skin melanoma | Male | 1.94 (1.14,2.62) | 8.41 (4.74,11.80) | 333.51 | 0.42 (0.26,0.57) | 0.93 (0.54,1.30) | 121.43 | | Female | 1.77 (1.09,2.85) | 8.53 (4.44,12.01) | 381.92 | 0.38 (0.24,0.61) | 0.91 (0.48,1.28) | 139.47 | | Both | 3.71 (2.57,5.21) | 16.94 (10.46,21.52) | 356.60 | 0.40 (0.28,0.56) | 0.92 (0.58,1.16) | 130.00 |
| | Hodgkin lymphoma | Male | 4.12 (1.94,5.49) | 6.22 (4.01,8.02) | 50.97 | 0.80 (0.38,1.07) | 0.78 (0.50,0.98) | -2.50 | | Female | 2.52 (1.07,3.57) | 3.24 (2.17,4.30) | 28.57 | 0.50 (0.21,0.70) | 0.40 (0.27,0.53) | -20.00 | | Both | 6.64 (3.48,8.67) | 9.47 (7.08,11.48) | 42.62 | 0.65 (0.34,0.84) | 0.57 (0.43,0.69) | -12.31 |
| | Other pharynx cancer | Male | 2.46 (2.03,2.93) | 7.68 (6.00,9.63) | 212.20 | 0.59 (0.49,0.70) | 0.77 (0.61,0.96) | 30.51 | | Female | 0.85 (0.71,1.00) | 2.41 (1.89,3.03) | 183.53 | 0.19 (0.16,0.22) | 0.24 (0.18,0.29) | 26.32 | | Both | 3.31 (2.83,3.80) | 10.09 (8.29,12.12) | 204.83 | 0.38 (0.33,0.43) | 0.49 (0.41,0.59) | 28.95 |
| | Mesothelioma | Male | 0.56 (0.43,0.80) | 1.71 (1.32,2.16) | 205.36 | 0.13 (0.10,0.18) | 0.18 (0.14,0.22) | 38.46 | | Female | 0.64 (0.41,1.04) | 1.10 (0.7,1.41) | 71.88 | 0.14 (0.09,0.23) | 0.11 (0.07,0.14) | -21.43 | | Both | 1.19 (0.91,1.67) | 2.81 (2.31,3.35) | 136.13 | 0.13 (0.10,0.19) | 0.14 (0.12,0.17) | 7.69 |
|
|
